MARSHALL WACE, LLP - BIOTECH ACQUISITION COMPANY ownership

BIOTECH ACQUISITION COMPANY's ticker is BIOTW and the CUSIP is G1125A116. A total of 53 filers reported holding BIOTECH ACQUISITION COMPANY in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of BIOTECH ACQUISITION COMPANY
ValueSharesWeighting
Q4 2022$5,807,501
+1.7%
575,0000.0%0.01%0.0%
Q3 2022$5,709,000
+0.3%
575,0000.0%0.01%
+8.3%
Q2 2022$5,693,000
+0.5%
575,0000.0%0.01%
+9.1%
Q1 2022$5,663,000
+0.1%
575,0000.0%0.01%
+10.0%
Q4 2021$5,656,000
+368.2%
575,000
+363.6%
0.01%
+100.0%
Q3 2021$1,208,000
+24.9%
124,022
+24.0%
0.01%
+25.0%
Q2 2021$967,000
+99.4%
99,993
+100.0%
0.00%
+100.0%
Q1 2021$485,00049,9930.00%
Other shareholders
BIOTECH ACQUISITION COMPANY shareholders Q2 2022
NameSharesValueWeighting ↓
Kingstown Capital 300,000$72,0000.11%
Telemetry Investments, L.L.C. 153,694$36,0000.06%
Kamunting Street Capital Management, L.P. 158,962$38,0000.05%
Radcliffe Capital Management, L.P. 202,950$2,001,0000.04%
Q Global Advisors, LLC 300,000$72,0000.04%
Integrity Capital Management (HK) Ltd 33,267$8,0000.04%
Corbin Capital Partners, L.P. 464,062$111,0000.02%
HGC Investment Management Inc. 1,215,782$292,0000.02%
Segantii Capital Management Ltd 50,000$493,0000.01%
Sage Rock Capital Management LP 286,900$69,0000.01%
View complete list of BIOTECH ACQUISITION COMPANY shareholders